Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2/PHASE3
30 participants
INTERVENTIONAL
2011-02-28
2012-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
three-dimensional glasses (Virtual Reality glasses)
Women in case group used the glasses for 30 minutes
three-dimensional glasses(manufactor Vuzix,wrap 920)
The samples were randomly allocated to use three-dimensional glasses for 30 minutes in order to reliving labor pain.
usual care
Women in control group did not use the glasses.
usual care
Women in Control group did not use the glasses.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
three-dimensional glasses(manufactor Vuzix,wrap 920)
The samples were randomly allocated to use three-dimensional glasses for 30 minutes in order to reliving labor pain.
usual care
Women in Control group did not use the glasses.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* low risk pregnancy
* primipara
Exclusion Criteria
* History of motion sickness or headaches
* psychological disease or Addiction
18 Years
29 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mashhad University of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Samira Ebrahimzadeh Zagami
MUMS
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Virtual Reality System
Identifier Type: -
Identifier Source: org_study_id